The mammalian urinary tract includes the kidneys, ureters, urinary bladder, and urethra. The renal parenchyma is composed of the glomeruli and a heterogeneous array of tubule segments that are specialized in both function and structure and are arranged in a specific spatial distribution. The ultrastructure of the glomeruli and renal tubule cpithelia have been well characterized and the relationship between the cellular structure and the function of the various components of the kidney have been the subject of intense study by many investigators. The lower urinary tract, the ureters, urinary bladder, and urethra, which are histologically similar throughout, are composed of a mucosal layer lined by transitional epithelium, a tunica muscularis, and a tunica serosa or adventitia. The present manuscript reviews the normal ultrastructural morphology of the kidney and the lower urinary tract. The normal ultrastructure is illustrated using transmission electron microscopy of normal rat kidney and urinary bladder preserved by in vivo perfusion with glutaraldehyde fixative and processed in epoxy resin.
1. Agre P, Brown D, and Nielsen S (1995). Aquaporin water channels: Unanswered questions and unresolved controversics.Curr. Opin. Cell. Biol.7: 472–483.
2.
2. Allen F and Tisher CC (1976). Morphology of the ascending thick limb of Henle.Kidney Int.9: 8–22.
3.
3. Alper SL, Natale J, Gluck S, Lodish HF, and Brown D (1989). Subtypes of intercalated cells in rat kidney collecting duct defined by antibodies against erythroid band 3 and renal vacuolar H+-ATP-ase.Proc. Natl. Acad. Sci. USA86: 5429–5433.
4.
4. Bendayan R (1996). Renal drug transport: A review.Pharmacotherapy16: 971–985.
5.
5. Bohrer MP, Baylis C, Humes HD, Glassock RJ, Robertson CR, and Brenner BM (1978). Permselectivity of the glomerular capillary wall. Facilitated filtration of circulating polycations.J. Clin. Invest.61: 72–78.
6.
6. Borke JL, Minami J, Verma A, Penniston JT, and Kumar R (1987). Monoclonal antibodies against human erythrocyte membrane Ca++-Mg++ adenosine triphosphatase pump recognize an epitope in the basolateral membrane of human kidney distal tubule cells.J. Clin. Invest.80: 1225–1231.
7.
7. Brenner BM, Bohrer MP, Baylis Ch, and Deen WM (1977). Determinants of glomerular permselectivity: Insights derived from observationsin vivo. Kidney Int.12: 229–237.
8.
8. Brown D, Hirsch S, and Gluck S (1988). An H+-ATPase in opposite plasma membrane domains in kidney epithelial cell subpopulations.Nature331: 622–624.
9.
9. Caulfield JP and Farquhar MG (1974). The permeability of glomerular capillaries to graded dextrans. Identification of the basement membrane as the primary filtration barrier.J. Cell Biol.63: 883–903.
10.
10. Chang RL, Deen WM, Robertson CR, and Brenner BM (1975). Permselectivity of the glomerular capillary wall: III. Restricted transport of polyanions.Kidney Int.8: 212–218.
11.
11. Clapp WL and Abrahamson DR (1994). Development and gross anatomy of the kidney. In: Renal Pathology: With Clinical and Functional Correlations, CC Tisher and BM Brenner (eds). J. B. Lippincott, Philadelphia, pp. 3–59.
12.
12. Clapp WL, Madsen KM, Verlander JW, and Tisher CC (1987). Intercalated cells of the rat inner medullary collecting duct.Kidney Int.31: 1080–1087.
13.
13. Clapp WL, Madsen KM, Verlander JW, and Tisher CC (1989). Morphologic heterogeneity along the rat inner medullary collecting duct.Lab Invest.60: 219–230.
14.
14. Davis JE, Hagedorn JP, and Bergmann LL (1981). Anatomy and ultrastructure of the ureter. In: The Ureter, H Bergman (ed). Springer-Verlag, New York, pp. 55–70.
15.
15. Flessner MF, Wall SM, and Knepper MA (1992). Ammonium and bicarbonate transport in rat outer medullary collecting ducts.Am. J. Physiol.262: F1–F7.
16.
16. Friedman PA and Gesek FA (1995). Cellular calcium transport in renal epithelia: Measurement, mechanisms, and regulation.Physiol. Rev.75: 429–471.
17.
17. Gosling JA and Dixon JS (1995). Embryology and anatomy. In: The Bladder, JM Fitzpatrick and RJ Krane (eds). Churchill Livingstone, New York, pp. 1–16.
18.
18. Hamm LL, Weiner ID, and Vehaskari VM (1991). Structural-functional characteristics of acid–base transport in the rabbit collecting duct.Semin. Nephrol.11: 453–464.
19.
19. Hansen GP, Tisher CC, and Robinson RR (1980). Response of the collecting duct to disturbances of acid-base and potassium balance.Kidney Int.17: 326–337.
20.
20. Hebert SC, Gamba G, and Kaplan M (1996). The electroneutral Na(+)-(K+)-Cl-cotransport family.Kidney Int.49: 1638–1641.
21.
21. Hediger MA, Smith CP, You G, Lee WS, Kanai Y, and Shayakul C (1996). Structure, regulation and physiological roles of urea transporters.Kidney Int.49: 1615–1623.
22.
22. Imai M and Yoshitomi K (1990). Heterogeneity of the descending thin limb of Henle's loop.Kidney Int.38: 687–694.
23.
23. Isozaki T, Verlander JW, and Sands JM (1993). Low protein diet alters urea transport and cell structure in rat initial inner medullary collecting duct.J. Clin. Invest.92: 2448–2457.
24.
24. Kaissling B and Kriz W (1979). Structural analysis of the rabbit kidney.Adv. Anal. Embryol. Cell Biol.56: 1–123.
25.
25. Kanwar YS and Farquhar MG (1979). Anionic sites in the glomerular basement membrane. In vivo and in vitro localization to the laminae rarae by cationic probes.J. Cell Biol.81: 137–153.
26.
26. Kerjaschki D (1994). Dysfunctions of cell biological mechanisms of visceral epithelial cell (podocytes) in glomerular diseases.Kidney Int.45: 300–313.
27.
27. Kim J, Tisher CC, Linser PJ, and Madsen KM (1990). Ultrastructural localization of carbonic anhydrase II in subpopulations of intercalated cells of the rat kidney.J. Am. Soc. Nephrol.1: 245–256.
28.
28. Knepper MA (1997). Molecular physiology of urinary concentrating mechanism: Regulation of aquaporin water channels by vasopressin.Am. J. Physiol.272: F3–F12.
29.
29. Kriz W and Kaissling B (1992). Structural organization of the mammalian kidney. In: The Kidney: Physiology and Pathophysiology, DW Seldin and G Giebisch (eds). Raven Press, New York, pp. 707–777.
30.
30. Kumar R and Penniston JT (1991). Widespread distribution of calcium pump in calcium-transporting tissues. Immunohistochemical studies.Contrib. Nephrol.91: 21–25.
31.
31. LeFurgey A and Tisher CC (1979). Morphology of rabbit collecting duct.Am. J. Anat.155: 111–124.
32.
32. Lemley KV and Kriz W (1994). Structure and function of the renal vasculature. In: Renal Pathology: With Clinical and Functional Correlations, BM Brenner (ed). J. B. Lippincott, Philadelphia, pp. 981–1026.
33.
33. Madsen KM and Brenner BM (1994). Structure and function of the renal tubule and interstitium. In: Renal Pathology, CC Tisher (ed). J. B. Lippincott, Philadelphia, pp. 606–641.
34.
34. Madsen KM, Clapp WL, and Verlander JW (1988). Structure and function of the inner medullary collecting duct.Kidney Int.34: 441–454.
35.
35. Madsen KM and Tisher CC (1986). Structural–functional relationship along the distal nephron.Am. J. Physiol.250: F1–F15.
36.
36. Maunsbach AB (1966). Observations on the segmentation of the proximal tubule in the rat kidney. Comparison of results from phase contrast, fluorescence and electron microscopy.J. Ultrastruct. Res.16: 239–258.
37.
37. Maunsbach AB (1976). Cellular mechanisms of tubular protein transport.Int. Rev. Physiol.11: 145–167.
38.
38. Mundel P and Kriz W (1995). Structure and function of podocytes: An update.Anat. Embryol. (Berl.)192: 385–397.
39.
39. Plotkin MD, Kaplan MR, Verlander JW, Lee WS, Brown D, Poch E, Gullans SR, and Herbert SC (1996). Localization of the thiazide sensitive Na-Cl cotransporter, rTSC1 in the rat kidney.Kidney Int.50: 174–183.
40.
40. Ridderstrale Y, Kashgarian M, Koeppen BM, Giebisch G, Stetson DL, Ardito T, and Stanton BA (1988). Morphological heterogeneity of the rabbit collecting duct.Kidney Int.34: 655–670.
41.
41. Sands JM and Knepper MA (1987). Urea permeability of mammalian inner medullary collecting duct system and papillary surface epithelium.J. Clin. Invest.79: 138–147.
42.
42. Sands JM, Martial S, and Isozaki T (1996). Active urea transport in the rat inner medullary collecting duct: Functional characterization and initial expression cloning.Kidney Int.49: 1611–1614.
43.
43. Sands JM, Nonoguchi H, and Knepper MA (1987). Vasopressin effects on urea and H2O transport in inner medullary collecting duct subsegments.Am. J. Physiol.253: F823–F832.
44.
44. Schlondorff D (1996). Roles of the mesangium in glomerular function.Kidney Int.49: 1583–1585.
45.
45. Schmidt Nielsen B (1995). August Krogh Lecture. The renal concentrating mechanism in insects and mammals: A new hypothesis involving hydrostatic pressures.Am. J. Physiol.268: R1087–R1100.
46.
46. Schnermann J and Briggs JP (1992). Function of the juxtaglomerular apparatus. Control of glomerular hemodynamics and renin secretion. In: The Kidney: Physiology and Pathophysiology, DW Seldin and G Giebisch (eds). Raven Press, Ltd., New York, pp. 1249–1289.
47.
47. Shayakul C and Hediger MA (1996). Mammalian urea transporters.Curr. Opin. Nephrol. Hypertens.5: 401–405.
48.
48. Teng-umnuay P, Verlander JW, Yuan W, Tisher CC, and Madsen KM (1996). Identification of distinct subpopulations of intercalated cells in the mouse collecting duct.J. Am. Soc. Nephrol.7: 260–274.
49.
49. Tisher CC and Brenner BM (1994). Structure and function of the glomerulus. In: Renal Pathology: With Clinical and Functional Correlations, CC Tisher and BM Brenner (eds). J. B. Lippincott, Philadelphia, pp. 143–161.
50.
50. Tisher CC and Madsen KM (1996). Anatomy of the kidney. In: The Kidney, BM Brenner (ed). W. B. Saunders, Philadelphia, pp. 3–71.
51.
51. Usuda N, Hanai T, and Nagata T (1995). Immunogold studies on peroxisomes: Review of the localization of specific proteins in vertebrate peroxisomes.Microsc. Res. Tech.31: 79–92.
52.
52. Velardo JT (1981). Histology of the ureter. In: The Ureter, H Bergman (ed). Springer-Verlag, New York, pp. 13–54.
53.
53. Verlander JW, Madsen KM, Cannon JK, and Tisher CC (1994). Activation of acid-secreting intercalated cells in rabbit collecting duct with ammonium chloride loading.Am. J. Physiol. (Renal Fluid Electrolyte Physiol.)266: F633–F645.
54.
54. Verlander JW, Madsen KM, Galla JH, Luke RG, and Tisher CC (1992). Response of intercalated cells to chloride depletion metabolic alkalosis.Am. J. Physiol.262: F309–F319.
55.
55. Verlander JW, Madsen KM, Low PS, Allen DP, and Tisher CC (1988). Immunocytochemical localization of band 3 protein in the rat collecting duct.Am. J. Physiol.255: F115–F125.
56.
56. Verlander JW, Madsen KM, and Tisher CC (1987). Effect of acute respiratory acidosis on two populations of intercalated cells in rat cortical collecting duct.Am. J. Physiol.253: F1142–F1156.
57.
57. Verlander JW, Madsen KM, and Tisher CC (1991). Structural and functional features of proton and bicarbonate transport in the rat collecting duct.Semin. Nephrol.11: 465–477.
58.
58. Wade JB, Stanton BA, Field MJ, Kashgarian M, and Giebisch G (1990). Morphological and physiological responses to aldosterone: time course and sodium dependence.Am. J. Physiol.259: F88–F94.
59.
59. Wall SM (1996). Ammonium transport and the role of the Na,K-ATPase.Miner. Electrolyte Metab.22: 311–317.
60.
60. Wall SM and Knepper MA (1990). Acid-base transport in the inner medullary collecting duct.Semin. Nephrol.10: 148–158.
61.
61. Wall SM, Sands JM, Flessner MF, Nonoguchi H, Spring KR, and Knepper MA (1990). Net acid transport by isolated perfused inner medullary collecting ducts.Am. J. Physiol.258: F75–F84.
62.
62. Welling LW and Hill JJ (1978). Shape of cells and intercellular channels in rabbit thick ascending limb.Kidney Int.13: 144–151.
63.
63. Welling LW and Welling DJ (1975). Surface areas of brush border and lateral cell walls in the rabbit proximal nephron.Kidney Int.8: 343–348.
64.
64. Yu AS, Hebert SC, Lee SL, Brenner BM, and Lytton J (1992). Identification and localization of renal Na(+)–Ca2+ exchanger by polymerase chain reaction.Am. J. Physiol.263: F680–F685.
65.
65. Zaar K (1992). Structure and function of peroxisomes in the mammalian kidney.Eur. J. Cell Biol.59: 233–254.
66.
1. Alden CL and Frith CH (1991). Urinary system. In: Handbook of Toxicologic Pathology, Haschek VM and Rousseaux CG (eds). Academic Press, New York, pp. 315–387.
67.
2. Alvares AP and Mannering GJ (1970). Two substrate kinetics of drug-metabolizing enzyme system of hepatic microsomes.Mol. Pharmacol.6: 202–212.
68.
3. Battenfeld R, Rahman Khater AE, Drommer W, Guenzel P, and Kaup FJ (1991). Ioxoglate induced light and electron microscope alterations in the renal proximal tubular epithelium of rats.Invest. Radiol.26: 35–39.
69.
4. Borghoff SJ, Short BG, and Swenberg JA (1990). Biochemical mechanism and pathobiology of a2u-globulin nephropathy.Annu. Rev. Pharmacol. Toxicol.30: 349–367.
70.
5. Bulger RE (1986). Kidney morphology: Updated 1985.Toxicol. Pathol.14: 13–25.
71.
6. Chen HHC, Yu C, Ueng TH, Liang CT, Chen BJ, Hong CC, and Chiang LY (1997). Renal toxic effects of water soluble polyalkyl-sulfonated C60 with an acute study in rats. 12th General Symposium on Fullerenes, Fullerenes Research Association, January 13–14, 1997, 28–29, in Tokyo, Japan (in Japanese or English).
72.
7. Chen HHC, Yu C, Ueng TH, Liang CT, Chen BJ, Hong CC, and Chiang LY (1997). Renal toxic effects of water soluble polyalkyl-sulfonated C60 with an acute study in rats.Fullerene Sci. Technol.5: 1387–1395.
73.
8. Chen SC, Lai MK, Hsieh CH, Chueh SC, Chiang LY, and Chen WC (1997). The effects of fullerenols on the preservation of canine renal grafts–-preliminary reports. 12th General Symposium on Fullerenes, Fullerenes Research Association, January 13–14, 1997, 31, in Tokyo, Japan (in Japanese or English).
74.
9. Chiang LY, Lu FJ, and Lin JT (1995). Free radical scavenging activity of water soluble fullerenols. J. Chem. Soc. Chem. Commun.1283–1284.
75.
10. Chiang LY, Lu FJ, and Lin JT (1995). Free radical scavenging activity of water soluble [60] fullerenols in whole blood associated with gastric cancer.Proc. Electrochemical Soc.95: 699–705.
76.
11. Chiang LY, Swirczewski JW, Hsu CS, Chowdhury SK, Cameron S, and Creegan K (1992). Multi-hydroxy additions onto C60, fullerene molecules”. J. Chem. Soc. Chem. Commun.1791–1793.
77.
12. Chiang LY, Upasani RB, and Swirczewski JW (1992). Versatile nitroniumchemistry for C60 fullerene functionalization.J. Am. Chem. Soc.114: 10154–10157.
78.
13. Christensen EI and Maunsbach AB (1979). Effects of dextran on lysosomal ultrastructure and protein digestion in renal proximal tubule.Kidney Int.16: 301–311.
79.
14. Diederich F and Thilgen C (1996). Covalent fullerene chemistry.Science271: 317–323.
80.
15. Greenlee WF and Poland A (1978). An improved assay of 7-ethoxycoumarin O-deethylase activity: Induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methyl-cholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dixoixin.J. Pharmacol. Exp. Ther.205: 596–605.
81.
16. Guengerich FP (1992). Metabolic activation of carcinogens.Pharmacol. Ther.54: 17–61.
82.
17. Halpert JR (1995). Structural basis of selective cytochrome P450 inhibition.Ann. Rev. Pharmacol. Toxicol.35: 29–53.
83.
18. Hsu HC, Lee YT, Chiang LY, and Chen WC (1997). Effects of water-soluble fullerene derivatives on lipoprotein oxidation. 12th General Symposium on Fullerenes, Fullerenes Research Association, January 13–14, 1997, 33, in Tokyo, Japan (in Japanese or English).
84.
19. Huang HC, Lu LH, and Chiang LY (1996). Antiproliferative effect of polyhydroxylated C60 on vascular smooth muscle cells.Proc. Electrochemical Soc.96: 403–406.
85.
20. Huang HC, Lu LH, and Chiang LY (1997). Possible mechanisms of antiproliferative effect of fullerenol on vascular smooth muscle cells, as compared with activities of vitamin C and E. 12th General Symposium on Fullerenes, Fullerenes Research Association, January 13–14, 1997, 32, in Tokyo, Japan (in Japanese or English).
86.
21. Imai Y, Ito A, and Sato R (1966). Evidence for biochemically different types of vesicles in the hepatic microsomal fraction.J. Biochem. (Tokyo)60: 417–428.
87.
22. Kosek JC, Mazze RI, and Cousins MJ (1974). Nephrotoxicity of gentamicin.Lab. Invest.30: 48–57.
88.
23. Krusic PJ, Wasserman E, Keiger PN, Morton JR, and Preston KF (1991). Radical reaction of C60.Science254: 1183–1185.
89.
24. Longnecker DS, Skinozuka H, and Farber E (1968). Molecular pathology of in vivo inhibition of protein synthesis.Am. J. Pathol.52: 891–915.
90.
25. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951). Protein determinations with Folin phenol reagent.J. Biol. Chem.193: 265–275.
91.
26. Maunsbach AB, Madden SC, and Latta H (1962). Light and electron microscopic changes in proximal tubules of rats after administration of glucose, mannitol, sucrose, or dextran.Lab. Invest.11: 421–432.
92.
27. Nash T (1953). The colorimetric estimation of formaldehyde by means of the Hantzoch reaction.Biochem. J.55: 416–421.
93.
28. Nebert DV and Gelboin HV (1968). Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme.J. Biol. Chem.243: 2642–2649.
94.
29. Omura T and Sato R (1964). The carbon monoxide-binding pigment of liver microcosms. I. Evidence for its hemoprotein nature.J. Biol. Chem.239: 2370–2378.
95.
30. Phillips AH and Lang don RG (1962). Hepatic triphosphopyridine nucleotide-cytochrome reductase: Isolation, characterization, and kinetic studies.J. Biol. Chem.237: 2652–2660.
96.
31. Ryan DE and Levin V (1990). Purification and characterization of hepatic microsomal cytochrome P450.Pharm. Ther.45: 153–239.
97.
32. Sijbesma R, Srdanov G, Wudl F, Castoro JA, Wilkins C, Friedman SH, DeCamp DL, and Kenyon GL (1993). Synthesis of a fullerene derivative for the inhibition of HIV enzymes.J. Am. Chem. Soc.115: 6510–6512.
98.
33. Tervahartiala P, Kivisaari L, Kivisaari R, Virtanen I, and Standertskjold-Nordenstam CG (1991). Contrast media-induced renal tubular vacuolization a light and electron microscopic study on rat kidneys.Invest. Radiol.26: 882–887.
99.
34. Tsai MC, Chen YH, and Chiang LY (1997). Polyhydroxylated C60, fullerenol, a novel free-radical trapper, prevented hydrogen peroxide-and cumene hydroperoxide-elicited changes in rat hippocampus in-vitro.J. Pharm. Pharmacol.49: 438–445.
100.
35. Tylor R and Walton DRM (1993). The chemistry of fullerenes.Nature363: 685–693.
101.
36. Ueng TH, Kang JJ, Wang HW, Cheng YW, and Chiang LY (1997). Suppression of microsomal cytochrome P450-dependent monooxygenases and mitochondrial oxidative phosphorylation by fullerenol, a polyhydroxylated fullerene C60.Toxicol. Lett.93: 29–37.
102.
1. Alpers CE, Hudkins KL, Gown AM, and Johnson RJ (1992). Enhanced expression of “muscle-specific” actin in glomerulonephritis.Kidney Int.41: 1134–1142.
103.
2. Alpers CE, Seifert RA, Hudkins KL, Johnson RJ, and Bowen-Pope DF (1993). PDGF-receptor localizes to mesangial, parietal epithelial, and interstitial cells in human and primate kidneys.Kidney Int.43: 286–294.
104.
3. Bachmann S, Le Hir M, and Eckardt KU (1993). Co-localization of erythropoietin mRNA and ecto-5′-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin.J. Histochem. Cytochem.41: 335–341.
105.
4. Barnes JL (1989). Glomerular localization of platelet secretory proteins in mesangial proliferative lesions induced by habu snake venom.J. Histochem. Cytochem.37: 1075–1082.
106.
5. Barnes JL (1997). Platelets in glomerular disease.Nephron77: 378–393.
107.
6. Barnes JL and Abboud HE (1993). Temporal expression of autocrine growth factors corresponds to morphological features of mesangial proliferation in habu snake venom-induced glomerulonephritis.Am. J. Pathol.143: 1366–1376.
108.
7. Barnes JL, Hastings RR, and De La Garza MA (1994). Sequential expression of fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis.Am. J. Pathol.145: 585–597.
109.
8. Barnes JL and Hevey KA (1990). Glomerular mesangial cell migration in response to platelet-derived growth factor.Lab. Invest.62: 379–382.
110.
9. Barnes JL and Hevey KA (1991). Glomerular mesangial cell migration: Response to platelet secretory products.Am. J. Pathol.138: 859–866.
111.
10. Barnes JL, Hevey KA, Hastings RR, and Bocanegra RA (1994). Mesangial cell migration precedes proliferation in habu snake venom-induced glomerular injury.Lab. Invest.70: 460–467.
112.
11. Barnes JL and Milani S (1995). In situ hybridization in the study of the kidney and renal diseases.Semin. Nephrol.15: 9–28.
113.
12. Barnes JL, Mitchell RJ, and Torres ES (1995). Expression of plasminogen activator-inhibitor-1 (PAI-1) during cellular remodeling in proliferative glomerulonephritis in the rat.J. Histochem. Cytochem.43: 895–905.
114.
13. Barnes JL, Mitchell RJ, and Torres ES (1996). Expression of cellular fibronectin (Fn-EHIA) and thrombospondin (TSP) during remodeling in habu snake venom-induced glomerulonephritis.J. Am. Assoc. Nephrol.7: 1752 (abstract).
115.
14. Barnes JL, Torres ES, Mitchell RJ, and Peters JH (1995). Expression of alternatively spliced fibronectin variants during remodeling in proliferative glomerulonephritis.Am. J. Pathol.147: 1361–1371.
116.
15. Brown LF, Dubin D, Lavigne L, Logan B, Dvorak H, and Van De Water L (1993). Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing.Am. J. Pathol.142: 793–801.
117.
16. Cattell V and Bradfield JWB (1977). Focal mesangial proliferative glomerulonephritis in the rat caused by habu snake venom.Am. J. Pathol.87: 511–524.
118.
17. Feinberg RF, Kao L-C, Haimowitz JE, Queenan JT Jr, Wun T-C, Strauss JF, and Kliman HJ (1989). Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. PAI-1 is an immunocyto-chemical marker of invading trophoblasts.Lab. Invest.61: 20–26.
119.
18. Ffrench-Constant C and Hynes RO (1989). Alternative splicing of fibronectin is temporally and spatially regulated in the chicken embryo.Development106: 375–388.
120.
19. Ffrench-Constant C, Van De Water L, Dvorak HF, and Hynes RO (1989). Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat.J. Cell Biol.109: 903–914.
121.
20. Gesualdo L, Di Paolo S, Milani S, Pinzani M, Grappone C, Ranieri E, Pannarale G, and Schena FP (1994). Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study.J. Clin. Invest.94: 50–58.
122.
21. Hugo C, Pichler R, Meek R, Gordon K, Kyriakides T, Floege J, Bornstein P, Couser WG, and Johnson RJ (1995). Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGFin vivo. Kidney Int.48: 1846–1856.
123.
22. Hynes RO (1990). Fibronectins.Springer-Verlag, New York.
124.
23. Iruela-Arispe L, Liska DJ, Sage EH, and Bornstein P (1993). Differential expression of thrombospondin 1, 2, and 3 during murine development.Dev. Dyn.197: 40–56.
125.
24. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzl P, Gordon K, and Gown AM (1991). Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation.J. Clin. Invest.87: 847–858.
126.
25. Lewis MEand Baldino (1991). Probes for in situ hybridization. In: In Situ Hybridization Histochemistry, M-F Chesselet (ed). CRC Press, Boca Raton, Florida, pp. 1–22.
127.
26. Matrisian LM (1990). Metalloproteinases and their inhibitors in matrix remodeling.Trends Genet.6: 121–125.
28. Morla A, Zhang Z, and Ruoslahti E (1994). Superfibronectin is a functionally distinct form of fibronectin.Nature367: 193–196.
130.
29. Pepper MS, Sappino A-P, Montesano R, Orci L, and Vassalli J-D (1992). Plasminogen activator inhibitor-1 is induced in migrating endothelial cells.J. Cell. Physiol.153: 129–139.
131.
30. Reed MJ, Puolakkainen P, Lane TF, Dickerson D, Bornstein P, and Sage EH (1993). Differential expression of SPARC and thrombospondin 1 in wound repair: Immunolocalization and in situ hybridization.J. Histochem. Cytochem.41: 1467–1477.
132.
31. Sage H and Bornstein P (1991). Extracellular proteins that modulate cell-matrix interactions. Sparc, tenascin, and thrombospondin.J. Biol. Chem.266: 14831–14834.
133.
32. Sappino A-P, Huarte J, Belin D, and Vassalli J-D (1989). Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos.J. Cell Biol.109: 2471–2479.
134.
33. Schlondorff D (1987). The glomerular mesangial cell: An expanding role for a specialized pericyte.Fed. Am. Soc. Exp. Biol. J.1: 272–281.
135.
34. Schneiderman J, Sawdey M, Craig H, Thinnes T, Bordin G, and Loskutoff DJ (1993). Type 1 plasminogen activator inhibitor gene expression following partial hepatectomy.Am. J. Pathol.143: 753–762.
136.
35. Shultz P, DiCorleto PE, Silver BJ, and Abboud HE (1988). Mesangial cells express PDGF mRNAs and proliferate in response to PDGF.Am. J. Physiol.255: F674–F684.
137.
36. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, and Sorg C (1994). Macrophages and angiogenesis.J. Leukoc. Biol.55: 410–422.
138.
37. Taraboletti G, Morigi M, Figliuzzi M, Giavazzi R, Zoja C, and Remuzzi G (1992). Thrombospondin induces glomerular mesangial cell adhesion and migration.Lab. Invest.67: 566–571.
139.
38. Tomooka S, Border WA, Marshall BC, and Noble NA (1992). Glomerular matrix accumulation is linked to inhibition of the plasmin protease system.Kidney Int.42: 1462–1469.
140.
39. Vassalli J-D, Sappino A-P, and Belin D (1991). The plasminogen activator/plasmin system.J. Clin. Invest.88: 1067–1072 (review).
141.
1. Aicher B and Kraupp O (1996). Zweckmassigkeit fixer Analgetikakombinationen am Beispiel von Thomapyrin. [Effectiveness of fixed analgesic combinations exemplified by thomapyrin.]Wien. Klin. Wochenschr.108: 219–233.
142.
2. Allen RC, Petty RE, Lirenman DS, Malleson PN, and Laxer RM (1986). Renal papillary necrosis in children with chronic arthritis.Am. J. Dis. Child.40: 20–22.
143.
3. Andersson B, Larsson R, Rahimtula A, and Moldeus P (1983). Hydroperoxide-dependent activation of p-phenetidine catalyzed by prostaglandin synthase and other peroxidases.Biochem. Pharmacol.32: 1045–1050.
144.
4. Anthony ML, Holmes E, McDowell PC, Gray TJ, Blackmore M, and Nicholson JK (1995). 1H-NMR spectroscopic studies on the reactions of haloalkylamines with bicarbonate ions: Formation of N-carbamates and 2-oxazolidones in cell culture media and blood plasma.Chem. Res. Toxicol.8: 1046–1053.
145.
5. Anthony ML, Rose VS, Nicholson JK, and Lindon JC (1995). Classification of toxin-induced changes in 1H-NMR spectra of urine using an artificial neural network.J. Pharm. Biomed. Anal.13: 205–211.
146.
6. Anthony ML, Sweatman BC, Beddell CR, Lindon JC, and Nicholson JK (1994). Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine.Mol. Pharmacol.46: 199–211.
147.
7. Arruda JAL, Sabatini S, Mehta PK, Sodhi B, and Baranowski R (1979). Functional characterization of drug-induced experimental papillary necrosis.Kidney Int.15: 264–275.
148.
8. Axelsen RA (1978). Experimental renal papillary necrosis in the rat: The selective vulnerability of medullary structures to injury.Virchows Arch. A Pathol. Anat. Histol.381: 79–84.
149.
9. Bach PH (1989). The detection of chemically induced renal injury the cascade of degenerative morphological and functional changes that follow the primary nephrotoxic insult and the evaluation of these changes by in vitro methods.Toxicol. Lett.46: 237–250.
150.
10. Bach PH (1991). Better diagnosis and mechanistic understandings of nephrotoxicity using histochemistry and cytochemistry.Prog. Histochem. Cytochem.23: 178–186.
151.
11. Bach PH and Bridges JW (1982). Synthesis of 2-bromo-[1–14C]-ethanamine hydrobromide.J. Labelled Compd. & Radiopharm.19: 425–431.
152.
12. Bach PH, and Bridges JW (1984). The role of prostaglandin synthase mediated metabolic activation of analgesics and non-steroidal anti-inflammatory drugs in the development of renal papillary necrosis and upper urothelial carcinoma.Prostaglandins Leukotrienes Med.15: 251–274.
153.
13. Bach PH and Bridges JW (1985). Chemically induced renal papillary necrosis and upper urothelial carcinoma.CRC Crit. Rev. Toxicol.15: 217–439.
154.
14. Bach PH, Christian R, Baker JR, and Bridges JW (1980). The metabolism of 2-bromo[1–14C]ethan-1-amine: A model compound for inducing renal papillary necrosis. In: Mechanisms of Toxicity and Hazard Evaluation, B Holmstedt, R Lauwerys, M Mercier, and M Roberfroid (eds). Elsevier, Amsterdam, pp. 533–536.
155.
15. Bach PH, Grasso P, Molland EA, and Bridges JW (1983). Changes in the medullary glycosaminoglycan histochemistry and microvascular filling during the development of 2-bromoethanamine hydrobromide-induced renal papillary necrosis.Toxicol. Appl. Pharmacol.69: 333–344.
156.
16. Bach PH and Gregg NJ (1988). Experimentally induced renal papillary necrosis and upper urothelial carcinoma.Int. Rev. Exp. Pathol.30: 1–54.
157.
17. Bach PH and Hardy TL (1985). The relevance of animal models to the study of analgesic associated renal papillary necrosis in man.Kidney Int.28: 605–613.
158.
18. Bach PH, Ketley CP, Dixit M, and Ahmed I (1986). The mechanisms of target cell injury in nephrotoxicity.Food Chem. Toxicol.24: 775–779.
159.
19. Bach PH, Scholey DJ, Delacruz L, Moret M, and Nichol S (1990). Renal and urinary lipid changes associated with an acutely induced renal papillary necrosis.Food Chem. Toxicol.29: 211–219.
160.
20. Barrett BJ (1996). Acetaminophen and adverse chronic renal outcomes: An appraisal of the epidemiologic evidence.Am. J. Kidney Dis.28: S14–S19.
161.
21. Bennett WM, Henrich WL, and Stoff JS (1996). The renal effects of nonsteroidal anti-inflammatory drugs: Summary and recommendations. Am. J. Kidney Dis.28(suppl. 1): S56–S62.
162.
22. Bilyard KG, Joseph EC, and Metcalf R (1990). Mesalazine: An overview of key preclinical studies.Scand. J. Gastroenterol. Suppl.25: 52–55.
163.
23. Black HE (1986). Renal toxicity of non-steroidal anti-inflammatory drugs.Toxicol. Pathol.14: 83–90.
164.
24. Blackshear JL, Napier JS, Davidman M, and Stillman MT (1985). Renal complications of nonsteroidal antiinflammatory drugs: Identification and monitoring of those at risk.Semin. Arthritis Rheum.14: 163–175.
165.
25. Bojesen IN (1980). In vitro and in vivo lipogenesis of the rat renal papillae from glucose.Biochim. Biophys. Acta619: 308–317.
166.
26. Bojesen IN (1974). Quantitative and qualitative analyses of isolated lipid droplets from interstitial cells in renal papillae from various species.Lipids9: 835–843.
167.
27. Bomhard EM, Falkenberg FW and Loof I (1994). Changes in urinary enzymes and kidney-derived antigens after acute renal papillary necrosis in rats.Kidney Int. Suppl.47: S60–S63.
168.
28. Braden GL, Kozinn DR, Hampf FE, Parker TH, and Germain MJ (1991). Ultrasound diagnosis of early renal papillary necrosis.J. Ultrasound Med.10: 401–403.
169.
29. Buckalew VM and Schey HM (1986). Renal disease from habitual antipyretic analgesic consumption: An assessment of the epidemiologic evidence.Medicine65: 291–303.
170.
30. Burrell JH, Yong JL, and MacDonald GJ (1991). Analgesic nephropathy in Fischer 344 rats: Comparative effects of chronic treatment with either aspirin or paracetamol.Pathology23: 107–114.
171.
31. Burrell JH, Yong JL, and MacDonald GJ (1991). Irreversible damage to the medullary interstitium in experimental analgesic nephropathy in F344 rats.J. Pathol.164: 329–338.
172.
32. Burry A (1978). Pathology of analgesic nephropathy: Australian experience.Kidney Int.13: 34–40.
173.
33. Bushell M-C, Inamdar R, Benns SE, Taylor D, Bridges JW, and Bach PH (1985). The application of proton nuclear magnetic resonance imaging to the evaluation of the site and severity of nephrotoxic lesions in rodents. In: Renal Heterogeneity and Target Cell Toxicity.PH Bach and EA Lock (eds). Wiley, Chichester, pp. 287–290.
174.
34. Carlton WW and Engelhardt JA (1989). Experimental renal papillary necrosis in the Syrian hamster.Food Chem. Toxicol.27: 331–340.
175.
35. Caruana RJ and Semble EL (1984). Renal papillary necrosis due to naproxen.J. Rheumatol.11: 90–91.
176.
36. Champion-De-Crespigny P, Hewitson T, Birchall I, and Kincaid-Smith P (1990). Caffeine potentiates the nephrotoxicity of mefenamic acid on the rat renal papilla.Am. J. Nephrol.10: 311–315.
177.
37. Chang DJ, Lamothe M, Stevens RM, and Sigal LH (1996). Dapsone in rheumatoid arthritis.Semin. Arthritis Rheum.25: 390–403.
178.
38. Chen PS, Caldwell RM, and Hsu CH (1984). Role of renal papillae in the regulation of sodium excretion during acute elevation of renal perfusion pressure in the rat.Hypertension6: 893–898.
179.
39. Cohen SM, Hasegawa R, Sakata T, and Johansson SL (1989). Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.Cancer Res.49: 372–377.
180.
40. Collins LG and Tyler DE (1984). Phenylbutazone toxicosis in the horse: A clinical study.J. Am. Vet. Med. Assoc.184: 699–703.
181.
41. Colome NE, Solans R, Espinach J, Delgadillo J, and Fonollosa V (1991). Renal papillary necrosis induced by flurbiprofen [letter].Drug Intell. Clin. Phann.25: 870–871.
182.
42. Cruz-Soto M, Frommer JP, Itsarayoungyuen K, Batlle DC, Arruda JA, and Kurtzman NA (1984). Carbonic anhydrase independent bicarbonate reabsorption in rats with chronic papillary necrosis.Miner. Electrolyte Metab.10: 319–325.
183.
43. Cuttino JT, Goss FU, Clark RL, and Marr MC (1981). Experimental renal papillary necrosis in rats: Microangiographic and tubular micropuncture injection studies.Invest. Radiol.16: 107–114.
184.
44. D'Agati V (1996). Does aspirin cause acute or chronic renal failure in experimental animals and in humans?Am. J. Kidney Dis.28: S24–S29.
185.
45. Davis BB, Mattammal MB, and Zenser TV (1981). Renal metabolism of drugs and xenobiotics.Nephron27: 187–196.
186.
46. De Broe ME and Elseviers MM (1993). Analgesic nephropathy–-Still a problem? [editorial].Nephron64: 505–513.
187.
47. De Broe ME, Elseviers MM, Bengtsson U, Mihatsch MJ, Molzahn M, Pommer W, Ritz E, and Schwarz A (1996). Analgesic nephropathy.Nephrol. Dial. Transplant.11: 2407–2408.
188.
48. Delzell E and Sapiro S (1996). Commentary on the National Kidney Foundation position paper on analgesics and the kidney.Am. J. Kidney Dis.28: 783–785.
189.
49. Dermer OC and Ham GE (1969). Ethylenimine and Other Aziridines.Academic Press, New York.
190.
50. Dubach UC, Rosner B, and Pflster E (1983). Epidemiologic study of abuse of analgesics containing phenacetin. Renal morbidity and mortality (1968–1979).N. Engl. J. Med.308: 357–362.
191.
51. Dubach C, Rosner B, and Sturmer T (1991). An epidemiologic study of abuse of analgesic drugs. Effects of phenacetin and salicylate on mortality and cardiovascular morbidity (1968 to 1987).N. Engl. J. Med.324: 155–160.
192.
52. Duggin GG (1996). Combination analgesic-induced kidney disease: The Australian experience.Am. J. Kidney Dis.28: S39–S47.
193.
53. Dunn MJ and Hood VL (1977). Prostaglandins and the kidney.Am. J. Physiol.223: F169–F184.
194.
54. Dunn MJ and Zambraski EJ (1980). Renal effects of drugs that inhibit prostaglandin synthesis.Kidney Int.18: 609–622.
195.
55. Eisenbrandt DL and Nitschke KD (1989). Inhalation toxicity of sulfuryl fluoride in rats and rabbits.Fundam. Appl. Toxicol.12: 540–557.
196.
56. Eknoyan G (1994). Current status of chronic analgesic and nonsteroidal anti-inflammatory drug nephropathy.Curr. Opin. Nephrol. Hypertens.3: 182–188.
197.
57. Elliott G, Whited BA, Purmalis A, Davis JP, Field SO, Lancaster C, and Robert A. (1986). Effect of 16,16-dimethyl PGE2 on renal papillary necrosis and gastrointestinal ulcerations (gastric, duodenal, intestinal) produced in rats by mefenamic acid.Life Sci.39: 423–432.
198.
58. Elseviers MM, Bosteels V, Cambier P, De Paepe M, Godon JP, Lins R, Lornoy W, Matthys E, Moeremans C, Roose R, et al (1992). Diagnostic criteria of analgesic nephropathy in patients with end-stage renal failure: Results of the Belgian study.Nephrol. Dial. Transplant.7: 479–486.
199.
59. Elseviers MM and De Broe ME (1989). Preventie van analgetica nefropathie. [Prevention of analgesic nephropathy.]Arch. Belg.47: 77–80.
200.
60. Elseviers MM and De Broe ME (1994). Analgesic nephropathy in Belgium is related to sales of particular analgesic mixtures.Nephrol. Dial. Transplant.9: 41–46.
201.
61. Elseviers MM and De Broe ME (1995). A long-term prospective controlled study of analgesic abuse in Belgium.Kidney Int.48: 1912–1919.
202.
62. Elseviers MM and De-Broe ME (1996). Combination analgesic involvement in the pathogenesis of analgesic nephropathy: The European perspective.Am. J. Kidney Dis.28: S48–S55.
203.
63. Elseviers MM, De Schepper A, Corthouts R, Bosmans J-L, Cosyn L, Lins RL, Lornoy W, Matthys E, Roose R, Van Caesbroeck D, Waller IHorackova M, Schwarz A, Svrcek P, Bonucchi D, Franek E, Morlans M, and De Broe ME (1995). High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure.Kidney Int.48: 1316–1323.
204.
64. Elseviers MM, Waller I, Nenoy D, Levora J, Matousovic K, Tanquerel T, Pommer W, Schwarz A, Keller E, Thieler H, et al (1995). Evaluation of diagnostic criteria for analgesic nephropathy in patients with end-stage renal failure: Results of the ANNE study. Analgesic Nephropathy Network of Europe.Nephrol. Dial. Transplant.10: 808–814.
205.
65. Elwell MR, Dunnick JK, Brown HR, and Montgomery CA (1989). Kidney and urinary bladder lesions in F344/N rats and B6C3F1 mice after 13 weeks of 2,2-bis(bromomethyl)-1,3-propanediol administration.Fundam. Appl. Toxicol.12: 480–490.
206.
66. Emkey RD (1983). Aspirin and renal disease.Am. J. Med.74: 97–101.
207.
67. Engelhardt G (1996). Effect of acetylsalicylic acid, paracetamol, caffeine and a combination of these substances on the renal prostaglandin E2, 6-keto-prostaglandin F1alpha, water, creatinine and electrolyte excretion of the rat.Arzneimittelforschung46: 509–512.
208.
68. Engelhardt G and Homma D (1996). Effects of acetylsalicylic acid, paracetamol and caffeine and a combination of these substances on kidney glutathione levels.Arzneimittelforschung46: 513–518.
209.
69. Faulkner LW, Erb HN, and King JM (1984). Renal papillary necrosis in equines.Bull. Environ. Contain. Toxicol.33: 379–381.
210.
70. Finney JS, Bach PH, Bushell M-C, Gregg NJ, and Taylor DA (1990). The application of proton nuclear magnetic resonance imaging for the in vivo characterisation of chemically induced renal lesions in rats over a prolonged time study.Magn. Reson. Imag.8: 713–721.
211.
71. Furman KI, Kundig H, and Lewin JR (1981). Experimental paracetamol nephropathy and pyelonephritis in rats.Clin. Nephrol.16: 271–275.
212.
72. Fuwa M and Waugh D (1968). Experimental medullary necrosis: Effects of diuresis and anti-diuresis.Arch. Pathol.85: 404–409.
213.
73. Garcia PA and Burg MB (1991). Renal medullary organic osmolytes.Physiol. Rev.71: 1081–1115.
214.
74. Garcia EJ, Takezawa K, and Roman RJ (1989). Natriuretic effect of atriopeptin III in rats with papillary necrosis.Am. J. Physiol.257: F859–F865.
215.
75. Gartland KP, Beddell CR, Lindon JC, and Nicholson JK (1991). Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine.Mol. Pharmacol.39: 629–642.
216.
76. Gartland KP, Bonner FW, and Nicholson JK (1989). Investigations into the biochemical effects of region-specific nephrotoxins.Mol. Pharmacol.35: 242–250.
217.
77. Gartland KP, Sanins SM, Nicholson JK, Sweatman BC, Beddell CR, and Lindon JC (1990). Pattern recognition analysis of high resolution 1H NMR spectra of urine. A nonlinear mapping approach to the classification of toxicological data.NMR Biomed.3: 166–172.
218.
78. Gloor FJ (1978). Changing concepts in pathogenesis and morphology of analgesic nephropathy as seen in Europe.Kidney Int.13: 27–33.
219.
79. Gobe GC and Axelsen RA (1991). The role of apoptosis in the development of renal cortical tubular atrophy associated with healed experimental renal papillary necrosis.Pathology23: 213–223.
220.
80. Gradus DB, Zuker N, and Barki Y (1989). Renal papillary necrosis in a child with rheumatic carditis treated with aspirin.Isr. J. Med. Sci.25: 196–198.
221.
81. Gregg NJ and Bach PH (1990). 2-Bromoethanamine nephrotoxicity in the nude mouse: An atypical targetting for the renal cortex.Int. J. Exp. Pathol.71: 659–670.
222.
82. Gregg NJ, Courtauld EA, and Bach PH (1990). Enzyme histochemical changes in an acutely-induced renal papillary necrosis.Toxicol. Pathol.18: 39–46.
223.
83. Gregg NJ, Courtauld EA, and Bach PH (1990). High resolution light microscopic morphological and microvascular changes in an acutely-induced renal papillary necrosis.Toxicol. Pathol.18: 47–55.
224.
84. Gregg NJ, Elseviers MM, DeBroe ME, and Bach PH (1989). The epidemiological and mechanistic basis of analgesic associated nephropathy.Toxicol. Lett.46: 141–152.
225.
85. Gregg NJ, Robbins MEC, Hopewell JW, and Bach PH (1990). The effect of paracetamol on the pathogenesis of bromoethanamine-induccd renal papillary necrosis in the pig.Renal Fail.12: 157–163.
226.
86. Grieve EM, Whiting PH, and Hawksworth GM (1990). Arachidonic-acid-dependent metabolism of 2-bromoethanamine to a toxic metabolite in rat medullary interstitial cell cultures.Toxicol. Lett.53: 225–226.
88. Gunson DE (1983). Renal papillary necrosis in horses.J. Am. Vet. Med. Assoc.182: 263–266.
229.
89. Gunson DE and Soma LR (1983). Renal papillary necrosis in horses after phenylbutazone and water deprivation.Vet. Pathol.20: 603–610.
230.
90. Hagiwara A, Diwan BA, and Ward JM (1986). Modifying effects of butylated hydroxyanisole, di(2-ethylhexyl)phthalate or indomethacin on mouse hepatocarcinogenesis initiated by N-nitrosodiethylamine.Jpn. J. Cancer Res.77: 1215–1221.
231.
91. Hard GC and Neal GE (1992). Sequential study of the chronic nephrotoxicity induced by dietary administration of ethoxyquin in Fischer 344 rats.Fundam. Appl. Toxicol.18: 278–287.
232.
92. Hardy TL and Bach PH (1984). The efffects of N-phenylanthranilic acid-induced renal papillary necrosis on urinary acidification and renal electrolyte handling.Toxicol. Appl. Pharmacol.75: 265–277.
233.
93. Hasegawa R, Takahashi M, Furukawa F, Toyoda K, Sato H, and Hayashi Y (1988). Co-carcinogenic effect of retinyl acetate on forestomach carcinogenesis of male F344 rats induced with butylated hydroxyanisole.Jpn. J. Cancer Res.79: 320–328.
234.
94. Heckmann U, von-Bassewitz DB, and Zidek W (1988). Effect on blood pressure of chemically induced renomedullectomy in normotensive and spontaneously hypertensive rats.J. Hypertens. Suppl.6: S482–484.
235.
95. Hedlund LW, Maronpot RR, Johnson GA, Cofer GP, Mills GI, and Wheeler CT (1991). Magnetic resonance microscopy of toxic renal injury induced by bromoethylamine in rats.Fundam. Appl. Toxicol.16: 787–797.
236.
96. Henrich WL (1988). Analgesic nephropathy.Am. J. Med. Sci.295: 561–568.
237.
97. Henrich WL, Agodoa LE, Barrett B, Bennett WM, Blantz RC, Buckalew VM, D'Agati VD, DeBroc ME, Duggin GG, Eknoyan G, et al (1996). National Kidney Foundation position paper. Analgesics and the kidney.Am. J. Kidney Dis.27: 162–165.
238.
98. Hewitson TD, Champion de Crespigny PJ, and Kincaid-Smith P (1991). Caffeine potentiation of mefenamic acid-induced lesions in the rat renal medulla.J. Pathol.165: 343–347.
239.
99. Hildebrandt DA and Banks RO (1987). Effect of atrial natriuretic factor on renal function in rats with papillary necrosis.Am. J. Physiol.252: F977–F980.
240.
100. Hill GS, Wyllie RG, Miller M, and Heptinstall RH (1972). Experimental papillary necrosis of the kidney: II Electron microscopic and histochemical studies.Am. J. Pathol.68: 213–234.
241.
101. Holmes E, Bonner FW, Gartland KP, and Nicholson JK (1990). Proton NMR monitoring of the onset and recovery of experimental renal damage.J. Pharm. Biomed. Anal.8: 959–962.
242.
102. Holmes E, Bonner FW, and Nicholson JK (1995). Comparative studies on the nephrotoxicity of 2-bromoethanamine hydrobromide in the Fischer 344 rat and the multimammate desert mouse(Mastomys natalensis). Arch. Toxicol.70: 89–95.
243.
103. Holmes E, Bonner FW, and Nicholson JK (1996). Comparative biochemical effects of low doses of mercury II chloride in the F344 rat and the multimammate mouse (Mastomys natalensis).Comp. Biochem. Physiol. C. Pharmacol. Toxicol. Endocrinol.114: 7–15.
244.
104. Holmes E, Bonner FW, Sweatman BC, Lindon JC, Beddell CR, Rahr E, and Nicholson JK (1992). Nuclear magnetic resonance spectroscopy and pattern recognition analysis of the biochemical processes associated with the progression of and recovery from nephrotoxic lesions in the rat induced by mercury(II) chloride and 2-bromoethanamine.Mol. Pharmacol.42: 922–930.
245.
105. Holmes E, Caddick S, Lindon JC, Wilson ID, Kryvawych S, and Nicholson JK (1995). 1H and 2H NMR spectroscopic studies on the metabolism and biochemical effects of 2-bromoethanamine in the rat.Biochem. Pharmacol.49: 1349–1359.
246.
106. Holmes E, Foxall PJ, Nicholson JK, Neild GH, Brown SM, Beddell CR, Sweatman BC, Rahr E, Lindon JC, Spraul M, et al (1994). Automatic data reduction and pattern recognition methods for analysis of 1H nuclear magnetic resonance spectra of human urine from normal and pathological states.Anal. Biochem.220: 284–296.
247.
107. Holmes E, Nicholson JK, Bonner FW, Sweatman BC, Beddell CR, Lindon JC, and Rahr E (1992). Mapping the biochemical trajectory of nephrotoxicity by pattern recognition of NMR urinanalysis.NMR Biomed.5: 368–372.
248.
108. Hughes JR, Oliveto AH, Helzer JE, Higgins ST, and Bickel WK (1992). Should caffeine abuse, dependence, or withdrawal be added to DSM-IV and ICS 10?Am. J. Psychiatry149: 33–40.
249.
109. Husserl FE, Lange RK, and Kantrow CM (1979). Renal papillary necrosis and pyelonephritis accompanying fenoprofen therapy.J. Am. Med. Assoc.242: 1896–1898.
250.
110. Jacobsson E and Sjoquist M (1995). Natriuresis obtained by intracerebroventricular infusion of hypertonic NaCl in rats with papillary necrosis.Acta Physiol. Scand.153: 75–80.
251.
111. Johansson SL and Anderstrom C (1988). The influence of antipyrene on N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced urinary tract carcinogenesis.Carcinogenesis9: 783–787.
252.
112. Johansson SL, Radio SJ, Saidi J, and Sakata T (1989). The effects of acetaminophen, antipyrine and phenacetin on rat urothelial cell proliferation.Carcinogenesis10: 105–111.
253.
113. Johansson SL, Sakata T, Hasegawa R, Zenser TV, Davis BB, and Cohen SM (1986). The effect of long-term administration of aspirin and sodium saccharin on the rat kidney.Toxicol. Appl. Pharmacol.86: 80–92.
254.
114. Johnson GA, Benveniste H, Black RD, Hedlund LW, Maronpot RR, and Smith BR (1993). Histology by magnetic resonance microscopy.Magn. Reson. Q.9: 1–30.
255.
115. Joshi S, Zenser TV, Mattammal MB, Herman CA, and Davis BB (1978). Kidney metabolism of acetaminophen and phenacetin.J. Lab. Clin. Med.92: 924–931.
256.
116. Kari F, Bucher J, Haseman J, Eustis S, and Huff J (1995). Longterm exposure to the anti-inflammatory agent phenylbutazone induces kidney tumors in rats and liver tumors in mice.Jpn. J. Cancer Res.86: 252–263.
257.
117. Kashida Y, Yoshida M, Ishii Y, Nomura M, and Kato M (1996). Examination of lesions in the urinary bladder and kidney of dogs induced by nefiracetam, a new nootropic agent.Toxicol. Pathol.24: 549–557.
258.
118. Keeler R and Wilson N (1989). Natriuretic response to hypervolemia is absent in rats with papillary necrosis.Am. J. Physiol.257: R422–R426.
259.
119. Kennedy SJ and Jones HB (1989). Renal pathology of orally administered L-tri-iodothyronine in the rat. In: Nephrotoxicity: Extrapolation from In Vitro to In Vivo, and Animals to Man, PH Bach and EA Lock (eds). Plenum Press, London, pp. 611–615.
260.
120. Khan KN, Brassard J, Kats A, Bunch R, Venturini C, Morris D, and Alden C (1998). Renal profile of cyclooxygenase-1 and cyclooxygenase-2 in dogs, rats, and human and nonhuman primates.Toxicol. Pathol.26: 167–168 (abstract).
261.
121. Kim HL (1991). Accumulation of ethoxyquin in the tissue.J. Toxicol. Environ. Health33: 229–236.
262.
122. Kim HL, Ray AC, and Calhoun MC (1992). Ovine urinary metabolites of ethoxyquin.J. Toxicol. Environ. Health37: 341–347.
263.
123. Knapp DW, Richardson RC, Bottoms GD, Teclaw R, and Chan TC (1992). Phase I trial of piroxicam in 62 dogs bearing naturally occurring tumors.Cancer Chemother. Pharmacol.29: 214–218.
264.
124. Knapp DW, Richardson RC, Chan TC, Bottoms GD, Widmer WR, DeNicola DB, Teclaw R, Bonney PL, and Kuczek T (1994). Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder.J. Vet. Intern. Med.8: 273–278.
265.
125. Knight EV, Kimball JP, Keenan CM, Smith IL, Wong FA, Barrett DS, Dempster AM, Lieuallen WG, Panigrahi D, Powers WJ, and Szot RJ (1996). Preclinical toxicity evaluation of tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, in Sprague-Dawley rats and beagle dogs.Fundam. Appl. Toxicol.33: 38–48.
266.
126. Kolaja GJ, Packwood WH, Bell RR, Ratke CC, and Stout CL (1994). Renal papillary necrosis and urinary protein alterations induced in Fischer-344 rats by D-ormaplatin.Toxicol. Pathol.22: 29–38.
267.
127. Kramer RA, Boyd MR, and Dees JH (1986). Comparative nephrotoxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU) and chlorozotocin: functional–structural correlations in the Fischer 344 rat.Toxicol. Appl. Pharmacol.82: 540–550.
268.
128. Kriz W and Bankir L (1988). A standard nomenclature for structures of the kidney.Am. J. Physiol.254: F1–F8.
269.
129. Kumagai Y, Lin LY, Schmitz DA, and Cho AK (1991). Hydroxyl radical mediated demethylenation of (methylenedioxy)phenyl compounds.Chem. Res. Toxicol.4: 330–334.
270.
130. Lai FM, Lai KN, and Chong YW (1987). Papillary necrosis associated with rifampicin therapy.Aust. N.Z. J. Med.17: 68–70.
271.
131. Lamley KV, and Kriz W (1991). Anatomy of the renal interstitium.Kidney Int.39: 370–381.
272.
132. Lee TC, Malone B, Woodard D, and Snyder F (1989). Renal necrosis and the involvement of a single enzyme of the de novo pathway for the biosynthesis of platelet-activating factor in the rat kidney inner medulla.Biochem. Biophys. Res. Commun.163: 1002–1005.
273.
133. Lehmann H, Hirsch U, Bauer E, Bauer M, Greischel A, Schmid J, and Schneider P (1996). Studies on the chronic oral toxicity of an analgesic drug combination consisting of acetylsalicylic acid, paracetamol and caffeine in rats including an electron microscopical evaluation of kidneys.Arzneimittelforschung46: 895–905.
274.
134. Lenz SD (1996). Investigation of regional glutathione levels in a model of chemically-induced renal papillary necrosis.Food Chem. Toxicol.34: 489–494.
275.
135. Lenz SD and Carlton WW (1990). Diphenylamine-induced renal papillary necrosis and necrosis of the pars recta in laboratory rodents.Vet. Pathol.27: 171–178.
276.
136. Lenz SD and Carlton WW (1991). Decreased incidence of diphenylamine-induced renal papillary necrosis in Syrian hamsters given dimethylsulphoxide.Food Chem. Toxicol.29: 409–418.
277.
137. Lenz SD, Turek JJ, and Carlton WW (1995). Early ultrastructural lesions of diphenylamine-induced renal papillary necrosis in Syrian hamsters.Exp. Toxicol. Pathol.47: 447–452.
278.
138. MacAllister CG, Morgan SJ, Borne AT, and Pollet RA (1993). Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses.J. Am. Vet. Med. Assoc.202: 71–77.
279.
139. MacKay RJ, French TW, Nguyen HT, and Mayhew IG (1983). Effects of large doses of phenylbutazone administration to horses.Am. J. Vet. Res.44: 774–780.
280.
140. Macklin AW and Szot RJ (1980). Eighteen month oral study of aspirin, phenacetin and caffeine in C57BL/6 mice.Drug Chem. Toxicol.3: 135–163.
281.
141. Maekawa A, Onodera H, Tanigawa H, Furuta K, Kanno J, Matsuoka C, Ogiu T, and Hayashi Y (1986). Lack of carcinogenicity of triethanolamine in F344 rats.J. Toxicol. Environ. Health19: 345–357.
282.
142. Maher JF (1984). Analgesic nephropathy. Observations, interpretations, and perspective on the low incidence in America.Am. J. Med.76: 345–348.
283.
143. Maiza A and Daley-Yates PT (1991). Prediction of the renal clearance of cimetidine using endogenous N-1-methylnicotinamide.J. Pharmacokinet. Biopharm.19: 175–188.
284.
144. Maiza A and Daley-Yates PT (1993). Variability in the renal clearance of cephalexin in experimental renal failure.J. Phannacokinet. Biopharm.21: 19–30.
285.
145. Mandal AK and Bohman SO (eds) (1980). The Renal Papilla and Hypertension.Plenum, New York, London.
286.
146. Manson MM, Green JA, and Driver HE (1987). Ethoxyquin alone induces preneoplastic changes in rat kidney whilst preventing induction of such lesions in liver by aflatoxin B1.Carcinogenesis8: 723–728.
287.
147. Manson MM, Green JA, Wright BJ, and Carthew P (1992). Degree of ethoxyquin-induced nephrotoxicity in rat is dependent on age and sex.Arch. Toxicol.66: 51–56.
288.
148. Maunsbach AN, Olsen TS, and Christensen EI (eds) (1980). Functional Ultrastructure of the Kidney.Academic Press, London.
289.
149. McCredie M and Stewart JH (1988). Does paracetamol cause urothelial cancer or renal papillary necrosis?Nephron49: 296–300.
290.
150. McCredie M, Stewart JH, Carter JJ, Turner J, and Mahony JF (1986). Phenacetin and papillary necrosis: Independent risk factors for renal pelvic cancer.Kidney Int.30: 81–84.
291.
151. McCredie M, Stewart JH, and Mahoney JF (1982). Is phenacetin responsible for analgesic nephropathy in New South Wales?Clin. Nephrol.17:134–140.
292.
152. Michielsen P and De Schepper P (1996). Combination analgesic involvement in the pathogenesis of analgesic nephropathy.Am. J. Kidney Dis.28: 959–960.
293.
153. Michielsen P and De Schepper P (1996). Analgesic nephropathy in Belgium: Confusion between prevalence and incidence.Am. J. Kidney Dis.28: 958–959.
294.
154. Mitchell H, Muirden KD, and Kincaid-Smith P (1982). Indomethacin-induced renal papillary necrosis in juvenile chronic arthritis.Lancet2: 558–559.
295.
155. Miyazawa K, Iimori Y, Makino M, Mikami T, and Miyasaka K (1985). Effects of some non-steroidal anti-inflammatory drugs and other agents on cyclooxygenase and lipoxygenase activities in some enzyme preparations.Jpn. J. Pharmacol.38: 199–205.
296.
156. Mohandas J, Duggin GG, Horvath JS, and Tiller DJ (1981). Metabolic oxidation of acetaminophen (paracetamol) mediated by cytochrome P-450 mixed function oxidase and prostaglandin endoperoxide synthetase in rabbit kidney.Toxicol. Appl. Pharmacol.61: 252–259.
297.
157. Mohandas J, Duggin GG, Horvath JS, and Tiller DJ (1981). Regional differences in peroxidatic activation of paracetamol (acetaminophen) mediated by cytochrome P-450 and prostaglandin endoperoxide synthetase in rabbit kidney.Res. Commun. Chem. Pathol. Pharmacol.34: 69–80.
298.
158. Mohandas J, Marshall JJ, Duggin GG, Horvath JS, and Tiller DJ (1984). Differential distribution of glutathione and glutathione-related enzymes in rabbit kidney.Biochem. Pharmacol.33: 1801.
299.
159. Molland EA (1978). Experimental renal papillary necrosis.Kidney Int.13: 5–14.
300.
160. Molland EA (1976). Aspirin damage in the rat kidney in the intact animal and after unilateral nephrectomy.J. Pathol.120: 43–48.
301.
161. Morel F (1992). Methods in kidney physiology: Past, present, and future.Annu. Rev. Physiol.54: 1–9.
302.
162. Muhalwas KK, Shah GM, and Winer RL (1981). Renal papillary necrosis caused by long-termingestion of pentazocine and aspirin.J. Am.-Med. Assoc.246: 867–868.
303.
163. Mullick FG (1984). Papillary necrosis, marked, associated with aspirin abuse and interstitial nephritis, acute and chronic.Mil. Med.149: 569–575.
304.
164. Munck A, Lindlar F, and Masshoff W (1970). Die Pigmentierung der Nierenpapillen und der Schleimhaut der ableitenden Harnwege bei der chronischen sklerosierenden interstitiellen Nephritis (“Phenacetinniere”).Virchows Arch. A Pathol. Anat.349: 323–331.
305.
165. Murai T, Iwata H, Otoshi T, Endo G, Horiguchi S, and Fukushima S (1993). Renal lesions induced in F344/DuCrj rats by 4-weeks oral administration of dimethylarsinic acid.Toxicol. Lett.66: 53–61.
306.
166. Murray G, Wyllie RG, Hill GS, Ramsden PW, and Heptinstall RH (1972). Experimental papillary necrosis of the kidney. I. Morphology and functional data.Am. J. Pathol.67: 285–302.
307.
167. Nafria EC, Solans R, Espinach J, Dclgadillo J, and Fonollosa V (1991). Renal papillary necrosis induced by flurbiprofen.Ann. Pharmacother.25: 870–887.
308.
168. Nakamura Y, Sasaki S, Shigai T, and Marumo F (1988). Effect of bromoethylamine hydrobromide on systemic acid-base balance.Tohoku J. Exp. Med.156: 23–32.
309.
169. Nakaura S, Tsuruta M, Tsunenari Y, Hongyo T, Ishii Y, and Kawase SA (1994). Single dose toxicity study of mesalazine in cynomolgus monkeys.Pharmacometrics47: 509–511.
310.
170. Nanra RS (1983). Renal effects of antipyretic analgesics.Am. J. Med.14: 70–81.
311.
171. Nanra RS (1993). Analgesic nephropathy in the 1990s. An Australian perspective.Kidney Int. Suppl.42: S86–S92.
312.
172. Nanra RS, Daniel V, and Howard M (1980). Analgesic nephropathy induced by common proprietary mixtures.Med. J. Aust.1: 486–487.
313.
173. Nelson SD, Dahlin DC, Rauckman RJ, and Rosen GM (1981). Peroxidase-mediated formation of reactive metabolites of acetaminophen.Mol. Pharmacol.20: 195–199.
314.
174. Noels LM, Elseviers MM, de Broe ME (1995). Impact of legislative measures on the sales of analgesics, and the subsequent prevalence of analgesic nephropathy: A comparative study in France, Sweden and Belgium.Nephrol. Dial. Transplant.10: 167–174
315.
175. Okamura T, Garland EM, Taylor RJ, Johansson SL, and Cohen SM (1992). The effect of cyclophosphamide administration on the kidney of the rat.Toxicol. Lett.63: 261–276.
316.
176. Okazaki S, Todate A, Yamazaki E, Anabuki K, Tamura K, Hoshiya T, Maruden A, and Terazawa K (1992). A 13-week subacute oral toxicity study of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl) amino] benzoate dimethanesulfonate (FUT-187) in rats.J. Toxicol. Sci.17: 17–59.
317.
177. Owen RA and Heywood R (1983). Phenylbutazone-induced nephrotoxicity in the rat.Toxicol. Lett.17: 117–124.
318.
178. Owen RA and Heywood R (1986). Strain-related susceptibility to nephrotoxicity induced by aspirin and phenylbutazone in rats.Toxicol. Pathol.14: 242–246.
319.
179. Pommer W, Bronder E, Greiser E, Helmert U, Jesdinsky HJ, Klimpel A, Borner K, and Molzahn M (1989). Regular analgesic intake and the risk of end-stage renal failure.Am. J. Nephrol.9: 403–412.
320.
180. Pommer W, Glaeske G, and Molzahn M (1986). The analgesic problem in the Federal Republic of Germany: Analgesic consumption, frequency of analgesic nephropathy and regional differences.Clin. Nephrol.26: 273–278.
321.
181. Poole A and Buckley P (1989). 1-Naphthol–-Single and repeated dose (30-day) oral toxicity studies in the mouse.Food Chem. Toxicol.27: 233–238.
322.
182. Porter GA (1996). Acetaminophen/aspirin mixtures: Experimental data. Am. J. Kidney Dis.28(suppl. 1): S30–S33.
323.
183. Powell CJ, Grasso P, Ioannides C, Wilson J, and Bridges JW (1991). Haloalkylamine induced renal papillary necrosis: A histopathological study of structure–activity relationships.Int. J. Exp. Pathol.72: 631–646.
324.
184. Pulliam JP and Bennett WM (1985). Analgesic-associated nephropathy. Unappreciated cause of renal dysfunction.Postgrad. Med.77: 183–185, 190–192.
325.
185. Rahman A, Segasothy M, Samad SA, Zulfiqar A, and Rani M (1993). Analgesic use and chronic renal disease in patients with headache.Headache33: 442–445.
326.
186. Read WK (1983). Renal medullary crest necrosis associated with phenylbutazone therapy in horses.Vet. Pathol.20: 662–669.
327.
187. Reyes JL, Hernandez ME, Melendez E, and Gomez-Lojero C (1995). Inhibitory effect of the antioxidant ethoxyquin on electron transport in the mitochondrial respiratory chain.Biochem. Pharmacol.49: 283–289.
328.
188. Rinke M, Bomhard EA, Hildebrand H, Leser KH, Loof I, and Ruehl-Fehlert C (1998). Serotonin (5-HT1A-receptor) agonist-induced collecting duct vacuolation and renal papillary necrosis in the rat.Toxicol. Pathol.26: 152–159.
329.
189. Ross R, Larsson B, Andersson U, Nilsson T, Lindquist B, Lindeke V, and Moldeus P (1985). The oxidation of p-phenetidine by horse radish peroxidase and prostaglandin synthase and the fate of glutathione during such oxidation.Biochem. Pharmacol.34: 343–351.
330.
190. Russell GI, Bing RF, Thurston H, and Swales JD (1987). Haemodynamic consequences of experimental papillary necrosis in the rat.Clin. Sci.72: 599–604.
331.
191. Ruwart MJ, Nichols NM, Rush BD, Mochizuki R, Elliott G, and Brunden MN (1985). 16,16-Dimethyl PGE2 partially prevents N-phenylanthranilic acid-induced kidney damage in the rat.Prostaglandins Leukotriene Med.20: 139–140.
332.
192. Sabatini S (1984). The pathophysiology of experimentally induced renal papillary necrosis.Semin. Nephrol.4: 27–38.
333.
193. Sabatini S (1984). Pathophysiology of drug-induced papillary necrosis.Fundam. Appl. Toxicol.4: 909–921.
334.
194. Sabatini S (1985). Cellular mechanisms of drug-induced papillary necrosis.J. Pharmacol. Exp. Ther.232: 214–219.
335.
195. Sabatini S (1989). Pathophysiologic mechanisms of abnormal collecting duct function.Semin. Nephrol.9: 179–202.
336.
196. Sabatini S (1996). Pathophysiologic mechanisms in analgesic-induced papillary necrosis.Am. J. Kidney Dis.28: S34–S38.
337.
197. Sabatini S, Alla V, Wilson A, Cruz-Soto M, De White A, Kurtzman NA, and Arruda JAL (1982). The effects of chronic papillary necrosis on acid excretion.Pflügers Arch.393: 262–268.
338.
198. Sabatini S, Koppera S, Manaligod J, Arruda JA, and Kurtzman NA (1983). Role of urinary concentrating ability in the generation of toxic papillary necrosis.Kidney Int.23: 705–710.
339.
199. Sabatini S, Mehta PK, Hayes S, Kurtzman NA, and Arruda JAL (1981). Drug-induced papillary necrosis: Electrolyte excretion and nephron heterogeneity.Am. J. Physiol.241: F14–F22.
340.
200. Sandler DP, Burr R, and Weinberg CR (1991). Nonsteroidal antiinflammatory drugs and the risk for chronic renal disease.Ann. Intern. Med.115: 165–172.
341.
201. Sandler DP, Smith JC, Weinberg CR, Buckalew VM, Dennis VW, Blythe WB, and Burgess WP (1989). Analgesic use and chronic renal disease.N. Engl. J. Med.320: 1238–1243.
342.
202. Scarlett JA, Gregg NJ, Nichol S, and Bach PH (1991). Strain differences in mice in their response to bromoethanamine. In: Nephrotoxicity: Mechanisms, Early Diagnosis and Therapeutic Management, PH Bach, NJ Gregg, MW Wilks, and L Delacruz (eds). Marcel Dekker, New York, pp. 79–84.
343.
203. Schwarz A (1987). Analgesic-associated nephropathy.Klin. Wochenschr.65: 1–16.
344.
204. Schwarz A, Kunzendorf U, Keller F, and Offermann G (1989). Progression of renal failure in analgesic-associated nephropathy.Nephron53: 244–249.
345.
205. Scott SJ, Bussey RA, et al. (1986). Renal papillary necrosis associated with diclofenac sodium.Br. Med. J.292: 1050.
346.
206. Segasothy M, Chin GL, Sia KK, Zulfiqar A, and Samad SA (1995). Chronic nephrotoxicity of anti-inflammatory drugs used in the treatment of arthritis.Br. J. Rheumatol.34: 162–165.
347.
207. Segasothy M and Gregory AR (1985). Renal papillary necrosis: Retrospective post-mortem study.Singapore Med. J.26: 61–63.
348.
208. Segasothy M, Kamal A, and Suleiman AB (1984). Renal papillary necrosis. Retrospective radiological study.Singapore Med. J.25: 254–258.
349.
209. Segasothy M, Thyaparan A, Kamal A, and Sivalingam S (1987). Mefenamic acid nephropathy.Nephron45: 156–157.
350.
210. Segasothy M, Tong BK, Kamal A, Murad Z, and Suleiman AB (1984). Analgesic nephropathy associated with paracetamol.Aust. N.Z. J. Med.14: 23–26.
351.
211. Shibata MA, Tanaka H, Yamada M, Tamano S, and Fukushima S (1989). Proliferative response of renal pelvic epithelium in rats to oral administration of ortho-phenylphenol sodium ortho-phenylphenate and diphenyl.Cancer Lett.48: 19–28.
352.
212. Shah GM, Muhalwas KK, and Winer RL (1981). Renal papillary necrosis due to ibuprofen.Arthritis Rheum.24: 1208–1210.
353.
213. Smith BJ, Curtis JF, and Eling TE (1991). Bioactivation of xenobiotics by prostaglandin H synthase.Chem.-Biol. Interact.79: 245–264.
354.
214. Smith WL and Wilkin GP (1977). Immunochemistry of prostaglandin endoperoxide-forming cyclooxygenase: The detection of the cyclooxygenases in rat rabbit and guinea pig kidneys by immunofluorescence.Prostaglandins13: 873–900.
355.
215. Spaethe SM, Hsueh W, and Needleman P (1989). Pharmacological manipulation of inflammation in rabbit hydronephrosis: Effects of a combined cyclooxygenase-lipoxygenase inhibitor ethoxyquin, a thromboxane synthase inhibitor RS-5186 and a PAF antagonist L-659989.J. Pharmacol Exp. Ther.248: 1308–1316.
356.
216. Stewart JH, McCredie M, Disney APS, Mathew TH (1994). Trends in incidence of end-stage renal failure in Australia, 1972–1991.Nephrol. Dial. Transplant.9: 1377–382.
357.
217. Stonard MD, Gore CW, Oliver GJ, and Smith IK (1987). Urinary enzymes and protein patterns as indicators of injury to different regions of the kidney.Fundam. Appl. Toxicol.9: 339–351.
358.
218. Sugawara T, Kato M, Suzuki N, Akahane K, and Takayama S (1994). Thirteen-week oral toxicity study of the new cognition-enhancing agent nefiracetam in dogs.Arzneimittelforschung44: 217–219.
359.
219. Thielemann LE, Rodrigo RA, Oberhauser EW, Rosenblut G, and Videla LA (1995). N-acetyl-L-cysteine abolishes the bromoethylamine-induced choline incorporation into renal papillary tissue.J. Biochem. Toxicol.10: 251–257.
360.
220. Thielemann LE, Rosenblut G, Cerda MC, Oberhauser EW, and De-Geyter MA (1991). Effect of different amino acidic pretreatments that protect the kidney against papillary necrosis induced by bromoethylamine on differential distribution of renal nonprotein sulfhydryls.J. Biochem. Toxicol.6: 155–159.
361.
221. Thuluvath PJ, Ninkovic M, Calam J, and Anderson M (1994). Mesalazine induced interstitial nephritis.Gut35: 1493–1496.
362.
222. Til HP, Woutersen RA, Feron VJ, Hollanders VH, Falke HE, and Clary JJ (1989). Two-year drinking-water study of formaldehyde in rats.Food Chem. Toxicol.27: 77–87.
363.
223. Torikai S (1986). Renal response to atrial natriuretic factor in rats without intact papillae.Clin. Sci.71: 277–282.
364.
224. Uemasu J, Fujiwara M, Munemura C, and Kawasaki H (1993). Long-term effects of enalapril in rat with experimental chronic tubulo-interstitial nephropathy.Am. J. Nephrol.13: 35–42.
365.
225. Vanholder R, Lameire N, Eeckhaut W, and Ringoir S (1981). Renal function studies in an experimental model of papillary necrosis in the rat.Arch. Int. Physiol. Biochim.89: 63–73.
366.
226. Whelton A (1995). Renal effects of over-the-counter analgesics.J. Clin. Pharmacol.35: 454–463.
367.
227. Whelton A and Hamilton CW (1991). Nonsteroidal anti-inflammatory drugs: Effects on kidney function.J. Clin. Pharmacol.31: 588–598.
368.
228. Whitbourn RJ, Henry MA, and Tange JD (1984). Pattern of renal cortical scarring after experimental papillary necrosis.Pathology16: 272–277.
369.
229. Wilks MF, Schmidt-Nielsen B, and Stolte H (1986). Early changes in renal function following chemically induced nephropathy.Clin. Physiol. Biochem.4: 239–251.
370.
230. Wolf DC, Carlton WW, and Turek JJ (1992). Experimental renal papillary necrosis in the Mongolian gerbil (Meriones unguiculatus).Toxicol. Pathol.20: 341–349.
371.
231. Wolf DC, Turek JJ, and Carlton WW (1992). Early sequential ultrastructural renal alterations induced by 2-bromoethylamine hydrobromide in the Swiss ICR mouse.Vet. Pathol.29: 528–535.
372.
232. Wright GJ and Rowe VK (1967). Ethyleneimine: Studies of the distribution and metabolism in the rat using carbon-14.Toxicol. Appl. Pharmacol.11: 575–584.
373.
233. Wyllie RG, Hill GS, Murray G, Ramsden PW, and Heptinstall RH (1972). Experimental papillary necrosis of the kidney. III Effects of reserpine and other pharmacological agents on the lesion.Am. J. Pathol.68: 235–254.
374.
234. Zenser TV, Mattammal MB, Brown WW, and Davis BB (1979). Cooxygenation by prostaglandin cyclooxygenase from rabbit inner medulla.Kidney Int.16: 688–694.
